NGL Fine-Chem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
October 28, 2022 at 09:18 am EDT
Share
NGL Fine-Chem Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 677.16 million compared to INR 783.66 million a year ago. Revenue was INR 681.87 million compared to INR 827.6 million a year ago. Net income was INR 46.69 million compared to INR 139.14 million a year ago. Basic earnings per share from continuing operations was INR 7.56 compared to INR 22.52 a year ago. Diluted earnings per share from continuing operations was INR 7.56 compared to INR 22.52 a year ago.
For the six months, sales was INR 1,323.25 million compared to INR 1,542.29 million a year ago. Revenue was INR 1,359.38 million compared to INR 1,631.73 million a year ago. Net income was INR 51.87 million compared to INR 330.4 million a year ago. Basic earnings per share from continuing operations was INR 8.4 compared to INR 53.48 a year ago. Diluted earnings per share from continuing operations was INR 8.4 compared to INR 53.48 a year ago.
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.
NGL FINE-CHEM LIMITED 
